flavone acetic acid has been researched along with Osteogenic Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bissery, MC; Corbett, T; De Neve, W; Evelhoch, J; Everett, C; Simpson, N; Valeriote, F | 1 |
Bissery, MC; Chabot, GG; Corbett, TH; Crissman, JD; Valeriote, FA; Yost, C | 1 |
Bissery, MC; Corbett, TH; Dieckman, J; Plowman, J; Polin, L; Tapazoglou, E; Valeriote, F; Wozniak, A | 1 |
3 other study(ies) available for flavone acetic acid and Osteogenic Sarcoma
Article | Year |
---|---|
Interaction between flavone acetic acid (LM-975, NSC 349512) and radiation in Glasgow's osteogenic sarcoma in vivo.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Combined Modality Therapy; DNA Damage; DNA Repair; DNA, Neoplasm; Flavonoids; Mice; Neoplasm Transplantation; Osteosarcoma | 1990 |
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo.
Topics: Animals; Antineoplastic Agents; Bone Marrow; DNA; DNA Damage; Dose-Response Relationship, Drug; Flavonoids; Leukemia P388; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Osteosarcoma; Time Factors | 1988 |
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Flavonoids; Lymphoma, Large B-Cell, Diffuse; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Pancreatic Neoplasms | 1986 |